Company News
PureTech hails "exciting" results from lung disease trial
Clinical-stage biotech group Puretech Health has announced promising results from the trial of its lung disease treatment deupirfenidone, which the lead investigator hailed as "extremely exciting".
Ricardo to sell Defense business, buy 85% stake in E3 Advisory
Strategic, environmental, and engineering consulting firm Ricardo said on Monday that it has agreed the sale of its Defense business to Proteus Enterprises and Gladstone Investment Corporation for $85m (£67. 5m).
Videndum shares drop on slow market recovery
Shares in media group Videndum tanked on Monday after the company warned of a slower-than-expected recovery in end-markets.
Kretinsky's Royal Mail takeover gets the green light
Czech billionaire Daniel Kretinsky's £3. 6bn takeover of Royal Mail has reportedly been approved by the government.
UK house prices fall again in December - Rightmove
New seller asking prices fell again in December as the market slowed down in the run-up to Christmas, but activity remained strong compared to last year, according to data released by Rightmove on Monday.
Entain hit with money-laundering lawsuit in Australia
Australia's financial crime regulator has started civil penalty proceedings against Entain Group related to alleged contraventions of an anti-money laundering and counter-terrorism financing act.
EU recommends expanding use of GSK endometrial cancer drug
GSK said the European Union's Committee for Medicinal Products for Human Use has recommended expanding approval of Jemperli in combination with chemotherapy for treatment of adults with primary advanced or recurrent endometrial cancer who are candidates for systemic therapy.